CAR T Cell Therapy Market Industry Trends and Global Forecasts to 2035: Rising Leukemia and Lymphoma Cases Boost CAR T Cell Therapy Market, with Positive Phase III Trials Expanding Treatment Potential
05 juin 2024 08h03 HE
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "CAR T Cell Therapy Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication, Target Antigens, Key Geographical...
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
04 juin 2024 16h05 HE
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
03 juin 2024 09h00 HE
|
Longeveron
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
Analysis of the Allogenic iNKT Cell Therapy Pipeline, 2024: Emerging Therapies, Products, Leading Companies, Unmet Needs, and More
31 mai 2024 06h07 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allogenic iNKT Cell Therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.Allogenic iNKT Cell Therapy...
Longeveron® to Attend BIO International Convention 2024
28 mai 2024 08h05 HE
|
Longeveron
Longeveron to attend BIO 2024, exploring potential partnership and strategic opportunities for its Alzheimer’s disease program.
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
28 mai 2024 08h00 HE
|
Neurona Therapeutics
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
28 mai 2024 08h00 HE
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to Surge to US$ 11.28 Billion by 2034, Propelled by Tranformative Cancer Treatments
27 mai 2024 09h43 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report...
Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
22 mai 2024 15h18 HE
|
National Health Regulatory Authority
MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the...
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease
22 mai 2024 06h55 HE
|
ANTION BIOSCIENCES SA
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases